Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM

Diabetes

Volumn 46, Issue 1, 1997, Pages 125-132

  Vergès, Bruno L ^a,b   Lagrost, Laurent ^a   Vaillant, Geneviève ^a   Petit, Jean M ^a   Cohen, Martine ^a   Gambert, Philippe ^a   Brun, Jean M ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CORRELATION FUNCTION; DIABETIC ANGIOPATHY; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031014384     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.125     Document Type: Article

References (40)

1. Utermann G, Beisiegel V: Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma: isolation and quantification. Eur J Biochem 99:333-343, 1979
2. Green PH, Glickman RM, Saudek CD, Blum CB, Tall AR: Human intestinal lipoproteins studies in chyluric subjects. J Clin Invest 64:233-342, 1979
3. Green PH, Glickman RM, Riley JW, Quinet E: Human apolipoprotein A-IV intestinal original and distribution in plasma. J Clin Invest 65:911-919, 1980
4. Weinberg RB, Scanu AM: Isolation and characterisation of human apolipoprotein A-IV from lipoprotein depleted serum. J Lipid Res 24:52-59, 1983
5. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL: Lipoprotein apoC-II activation of lipoprotein lipase: modulation by apolipoprotein A-IV. J Biol Chem 265:4266-4272, 1990
6. Steinmetz A, Utermann G: Activation of lecithin cholesterol acyl transferase by human apolipoprotein A-IV. J Biol Chem 260:2258-2264, 1985
7. Chen CH, Albers JJ: Activation of lecithin cholesterol acyl transferase by apolipoproteins E-2, E-3 and A-IV isolated from human plasma. Biochim Biophys Acta 836:279-285, 1985
8. Savion N, Gamliel A: Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells. Arteriosclerosis 8:178-186, 1988
9. Dvorin E, Gorder NL, Benson DM, Gotto AM Jr: Apolipoprotein A-IV: a determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem 261:15714-15718, 1986
10. Weinberg RB, Patton CS: Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1044:255-261, 1990
11. Stein O, Stein Y, Lefevre M, Roheim PS: The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from another analog of phosphatidylcholine. Biochim Biophys Acta 878:7-13, 1986
12. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart J-C, Ailhaud G: Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265:7859-7863, 1990
13. Lagrost L, Gambert P, Dangremont V, Athias A, Lallemant C: Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies. J Lipid Res 31:1569-1575, 1990
14. Guyard-Dangremont V, Lagrost L, Gambert P: Comparative effects of purified apolipoproteins A-I, A-II and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 35:982-992, 1994
15. Weinberg RB, Ibdah JA, Phillips MC: Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface a model for its labile binding to high density lipoproteins. J Biol Chem 267:8977-8983, 1992
16. Menzel HJ, Kövary PM, Assmann G: Apolipoprotein A-IV polymorphism in man. Hum Genet 62:349-352, 1982
17. Lohse P, Brewer HB Jr: Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipidol 2:90-95, 1991
18. Kamboh MI, Williams ER, Law JC, Aston CE, Bunker CH, Ferrell RE, Pollitzer WS: Molecular basis of a unique African variant (A-IV-5) of human apolipoprotein A-IV and its significance in lipid metabolism. Genet Epidemiol 9:379-388, 1992
19. Weinberg RB, Jordan MK, Steinmetz A: Distinctive structure and function of apolipoprotein variant apoA-IV-2. J Biol Chem 265:18372-18378, 1990
20. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI: Phenotypic effects of apolipoprotein structural variation on lipid profiles: apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 6:493-499, 1989
21. Rader DJ, Schäfer J, Lohse P, Vergès B, Kindt M, Zech LA, Steinmetz A, Brewer HB Jr: Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein. J Clin Invest 92:1009-1017, 1993
22. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613-628, 1987
23. Reaven GM: Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Am J Med 83 (Suppl. 3A):31-40, 1987
24. Taskinen MR, Harno K, Nikkila EA: Serum lipids and lipoproteins in type 2 diabetes. Acta Endocrinol 105 (Suppl. 262):95-99, 1984
25. Vergès B, Vaillant G, Goux A, Lagrost L, Brun JM, Gambert P: Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Diabetes Care 17:810-817, 1994
26. West KM, Ahuja MM, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, Grab B, Grabowskas OM: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6:361-369, 1983
27. Standl E, Stiegler H, Jonka HV, Mehnert M: Risk profile of vascular disease in diabetes mellitus. Diabetes Metab 14:505-511, 1988
28. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32:300-304, 1989
29. 2-cholesterol level and on its relationship with prevalence of atherosclerosis in type 2 diabetes. Diabetes Metab 18:289-297, 1992
30. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. 2nd ed. Geneva, World Health Organization, 1982
31. Prineas RJ, Crous RS, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings Standards and Procedures for Measurement and Classification. Boston, John Wright, 1982
32. Marinelli MR, Beach KW, Glass MS, Primozich SF, Standness DE: Noninvasive testing vs clinical evaluation of arterial disease. JAMA 241:2031-2034, 1979
33. Weinfeld FD: The national survey of stroke. Stroke 12 (Suppl. 1):32-35, 1981
34. Lagrost L, Gambert P, Meunier S, Morgado P, Desgres J, d'Athis P, Lallemant C: Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J Lipid Res 30:701-710, 1989
35. Lagrost L, Gambert P, Boquillon M, Lallemant C: Evidence for high density lipoproteins as the major apolipoprotein A-IV containing fraction in normal human serum. J Lipid Res 30:1525-1534, 1989
36. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G: Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoproteins levels. Hum. Genet 79:368-372, 1988
37. Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF: ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients: The San Luis Valley Diabetes Study. Diabetes 43:1485-1489, 1994
38. Weinberg RB, Spector MS: The self association of human apolipoprotein A-IV: evidence for an in vivo circulating dimeric form. J Biol Chem 260:14279-14286, 1985
39. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
40. Menzel HJ, Sigurdson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G: Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84:344-346, 1990